Focus on Molecules: Tear lipocalin

Experimental Eye Research

Volumn 92, Issue 4, 2011, Pages 242-243

  Glasgow, Ben J ^a,b   Gasymov, Oktay K ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticalins; Cornea; Dry eye disease; Lipid binding; Lipocalin 1; Rifampin; Tear lipocalin; Von Ebner's gland protein

Indexed keywords

LIPOCALIN 1;

HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; SHORT SURVEY;

CORNEA; DRY EYE SYNDROMES; EYE PROTEINS; HUMANS; LIPID METABOLISM; LIPOCALIN 1; TEARS;

EID: 79952626682     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.08.018     Document Type: Short Survey

References (4)

1. Breustedt D.A., Chatwell L., Skerra A. A new crystal form of human tear lipocalin reveals high flexibility in the loop region and induced fit in the ligand cavity. Acta Crystallogr. D Biol. Crystallogr. 2009, 65:1118-1125. (and references therein).
2. Gasymov O.K., Abduragimov A.R., Glasgow B.J. Intracavitary ligand distribution in tear lipocalin by site-directed tryptophan fluorescence. Biochemistry 2009, 48:7219-7228. (and references therein).
3. Glasgow B.J., Gasymov O.K., Abduragimov A.R., Engle J.J., Casey R.C. Tear lipocalin captures exogenous lipid from abnormal corneal surfaces. Invest. Ophthalmol. Vis. Sci. 2010, 51:1981-1987.
4. Millar T.J., Mudgil P., Butovich I.A., Palaniappan C.K. Adsorption of human tear lipocalin to human meibomian lipid films. Invest. Ophthalmol. Vis. Sci. 2009, 50:140-151.